apadaz
(Benzhydrocodone and Acetaminophen)Zevra Therapeutics, Inc.
Usage: APADAZ is indicated for short-term (up to 14 days) management of acute pain severe enough to require an opioid analgesic when alternatives are inadequate. It is reserved for patients who cannot tolerate non-opioid treatments or where such treatments do not provide sufficient pain relief.